We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

129 hedge funds and large institutions have $628M invested in Arena Pharmaceuticals Inc in 2014 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 33 increasing their positions, 44 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less capital invested

Capital invested by funds: $645M → $628M (-$16.9M)

10% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 21

2% less funds holding

Funds holding: 131 → 129 (-2)

25% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 44

47% less call options, than puts

Call options by funds: $22.8M | Put options by funds: $43.1M

Holders
129
Holders Change
-2
Holders Change %
-1.53%
% of All Funds
3.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
33
Reduced
44
Closed
21
Calls
$22.8M
Puts
$43.1M
Net Calls
-$20.2M
Net Calls Change
+$4.67M

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$19.9M
2
Norges Bank
Norges Bank
Norway
+$13.7M
3
Morgan Stanley
Morgan Stanley
New York
+$8.89M
4
Group One Trading
Group One Trading
Illinois
+$4.34M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.6M

Top Sellers

Rank Fund Capital Flow
1
BA
BlackRock Advisors
Delaware
-$6.18M
2
BFA
BlackRock Fund Advisors
California
-$4.12M
3
Goldman Sachs
Goldman Sachs
New York
-$3.68M
4
State Street
State Street
Massachusetts
-$3.57M
5
Bank of America
Bank of America
North Carolina
-$3.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
FA
101
FCG Advisors
New Jersey
$62K – – –
WAM
102
World Asset Management
Michigan
$59K -$9.57K -152 -13%
MCM
103
MAI Capital Management
Ohio
$59K +$63K +1,000 New
LIA
104
LS Investment Advisors
Michigan
$57K – – –
BRWA
105
B. Riley Wealth Advisors
Florida
$49.6K -$41.1K -653 -44%
Teacher Retirement System of Texas
106
Teacher Retirement System of Texas
Texas
$47K -$2.46K -39 -5%
LTFS
107
Ladenburg Thalmann Financial Services
Florida
$40K – – –
Bank of Montreal
108
Bank of Montreal
Ontario, Canada
$35K +$15K +239 +65%
BlackRock
109
BlackRock
New York
$34K -$2.83K -45 -7%
SO
110
STRS Ohio
Ohio
$33K – – –
Royal Bank of Canada
111
Royal Bank of Canada
Ontario, Canada
$33K +$1.07K +17 +3%
Ameriprise
112
Ameriprise
Minnesota
$24K -$126 -2 -0.5%
MFS
113
MSI Financial Services
Massachusetts
$15K -$23.3K -370 -60%
WA
114
Winfield Associates
Ohio
$11K – – –
PMFA
115
Plante Moran Financial Advisors
Michigan
$10K – – –
Fifth Third Bancorp
116
Fifth Third Bancorp
Ohio
$9K – – –
SF
117
Synovus Financial
Georgia
$9K – – –
WA
118
WFG Advisors
Texas
$6K – – –
BWFA
119
Baltimore-Washington Financial Advisors
Maryland
$6K +$6.3K +100 New
TRCT
120
Tower Research Capital (TRC)
New York
$4K -$44K -698 -92%
ST
121
Spot Trading
Illinois
$4K -$4.41K -70 -51%
JWA
122
JFS Wealth Advisors
Pennsylvania
$4K +$4.66K +74 New
NES
123
New England Securities
New York
$3K +$3.15K +50 New
BNP Paribas Financial Markets
124
BNP Paribas Financial Markets
France
$3K +$3.21K +51 New
BRWM
125
B. Riley Wealth Management
Tennessee
$2K – – –
2 3 4
5
6

ARNA Hedge Fund Activity: Q2 2014 in Review

129 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q2 2014, worth a combined $628M — down 2.6% from $645M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of ARNA and 19 opened new positions — a net loss of 2 holders — while 44 trimmed existing stakes and 33 added.

The largest buyer was Deerfield Management, adding an estimated $19.9M. The largest seller was BlackRock Advisors, cutting an estimated $6.18M.

  • 129 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q2 2014, down from 131 in Q1 2014.
  • Funds reported $628M of Arena Pharmaceuticals Inc stock for Q2 2014, down 2.6% quarter-over-quarter.
  • 19 funds opened new Arena Pharmaceuticals Inc positions in Q2 2014 and 21 closed out, a net change of -2 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q2 2014 was Deerfield Management, an estimated $19.9M added.
  • The largest Arena Pharmaceuticals Inc seller in Q2 2014 was BlackRock Advisors, an estimated $6.18M sold.

Based on aggregated 13F filings for Q2 2014.